Use of sildenafil in patients with severe COVID-19 pneumonitis.
Ontology highlight
ABSTRACT:
SUBMITTER: McFadyen C
PROVIDER: S-EPMC9010282 | biostudies-literature | 2022 Jul
REPOSITORIES: biostudies-literature
Publications
Use of sildenafil in patients with severe COVID-19 pneumonitis.
McFadyen Charles C Garfield Ben B Mancio Jennifer J Ridge Carole A CA Semple Tom T Keeling Archie A Ledot Stephane S Patel Brijesh B Samaranayake Chinthaka B CB McCabe Colm C Wort S John SJ Price Susanna S Price Laura C LC
British journal of anaesthesia 20220415 1
Similar Datasets
Project description: Not available
| S-BSST416 | biostudies-other
Project description:Lung transplantation can potentially be a life-saving treatment for patients with non-resolving COVID-19-associated respiratory failure. Concerns limiting transplant include recurrence of SARS-CoV-2 infection in the allograft, technical challenges imposed by viral-mediated injury to the native lung, and potential risk for allograft infection by pathogens associated with ventilator-associated pneumonia in the native lung. Most importantly, the native lung might recover, resulting in long-term outcomes preferable to transplant. Here, we report results of the first successful lung transplantation procedures in patients with non-resolving COVID-19-associated respiratory failure in the United States. We performed sm-FISH to detect both positive and negative strands of SARS-CoV-2 RNA in the explanted lung tissue, extracellular matrix imaging using SHIELD tissue clearance, and single cell RNA-Seq on explant and warm post-mortem lung biopsies from patients who died from severe COVID-19 pneumonia. Lungs from patients with prolonged COVID-19 were free of virus but pathology showed extensive evidence of injury and fibrosis which resembled end-stage pulmonary fibrosis. We used a machine learning approach to project single cell RNA-Seq data from patients with late stage COVID-19 onto a single cell atlas of pulmonary fibrosis, revealing similarities across cell lineages. There was no recurrence of SARS-CoV-2 or pathogens associated with pre-transplant ventilator associated pneumonias following transplantation. Our findings suggest that some patients with severe COVID-19 develop fibrotic lung disease for which lung transplantation is the only option for survival.
2020-10-28 | GSE158127 | GEO
Project description:Analysis of COVID-19 hospitalized patients, with different kind of symptoms, by human rectal swabs collection and 16S sequencing approach.
2022-09-22 | E-MTAB-12236 | biostudies-arrayexpress
Project description:We isolated PBMC from healthy, moderate ( Oxygen supply < 10L/min), and severe (Oxygen supply >= 10L/min) COVID-19 patients after their admission to Intensive Care Units (ICU), at two timepoints (Day-1 and Day-4); and performed both CD14+ Monocyte enrichment followed by a Pan-DC kit to retrieve all Antigen Presenting Cell (APC) subsets from these age-matched patients. We performed single cell RNA sequencing using 10X technology on the single cell suspensions and constracted a high-resolution map of 81,643 Antigen Presenting Cells (APC) from the three COVID-19 severity groups. We were able to retrieve all the known six APC subsets and deciphered the altered pathways and ati-viral mechanisms, correlated with the disease severity.
2021-05-10 | GSE169346 | GEO
Project description: Not available
| S-EPMC9513984 | biostudies-literature
Project description:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel viral pathogen that causes a clinical disease called coronavirus disease 2019 (COVID-19). Approximately 20% of infected patients experience a severe manifestation of the disease, causing bilateral pneumonia and acute respiratory distress syndrome. Severe COVID-19 patients also have a pronounced coagulopathy with approximately 30% of patients experiencing thromboembolic complications. However, the cellular etiology driving the coagulopathy remains unknown. Here, we explore whether the prominent neutrophilia seen in severe COVID-19 patients contributes to inflammation-associated coagulation. We found in severe patients the emergence of a CD16Int low-density inflammatory band (LDIB) neutrophil population that trends over time with changes in disease status. These cells demonstrated spontaneous neutrophil extracellular trap (NET) formation, higher phagocytic capacity, enhanced cytokine production, and associated clinically with D-dimer, ferritin, and systemic IL-6 and TNF-α levels. Strikingly, LDIB neutrophils are the major immune cells within the bronchoalveolar lavage (BAL) fluid with increased CXCR3 and loss of CD44 and CD38 expression. We conclude that the LDIB subset contributes to COVID- 19-associated coagulopathy (CAC) and systemic inflammation and could be used as an adjunct clinical marker to monitor disease status and progression. Identifying patients who are trending towards LDIB crisis and implementing early, appropriate treatment could improve all-cause mortality rates for severe COVID-19 patients.
2021-07-20 | GSE154311 | GEO
Project description:We profiled the single-cell transcriptomes of 13,289 peripheral blood mononuclear cells isolated at three longitudinal stages from two severe COVID-19 patients treated with Tocilizumab. The raw sequencing data can be obtained from the Genome Sequence Archive for Human (GSA-Human) at https://bigd.big.ac.cn/gsa-human/browse/HRA000172 .
2020-07-21 | GSE150861 | GEO
Project description:Severe lung damage in COVID-19 is known to involve complex interactions between diverse populations of immune and stromal cells. The pneumonitis manifesting in COVID-19 and acute respiratory distress syndrome results in spatially heterogenous manifestations of injury, such as infiltrates, loss of epithelial integrity and fibrosis. In this study, we applied a spatial transcriptomics approach to better delineate the cells, pathways and genes responsible for promoting and perpetuating severe tissue pathology in COVID-19 pneumonitis. Guided by tissue histology and multiplex immunofluorescence, we performed a targeted sampling of dozens of regions representing a spectrum of diffuse alveolar damage (mild to severe) from the post-mortem lung of three COVID-19 patients. These microscopic sites of injury had varying known compositions of CD3+ lymphocytes, CD68+ myeloid cells and panCK+ epithelial cells. DCC files are the processed sequencing files using the NanoString DND pipeline. The "Initial Dataset.xlsx" is represents raw gene counts for each probe replicate (n=47). "Post Biological Probe QC.xlsx" removes a sample (n=46) with failed sequencing (no rawReads) and conducts biological probe quality controls to collapse probe replicates into a single count per target gene using the GeoMx Analysis suite (version 2.1.0.102). "qn.exprs.tsv" is the matrix of quantile normalised gene expression by segment (n=46) and "qn.exprs.corrected.tsv" is the matrix of quantile normalised and batch corrected matrix of gene expression by segment (n=46). Rendered multichannel immunofluorescent microscopy png images corresponding to each area of interest (AOI with the acquistion borders outlined in white) are included. Further images can be made available upon request.
2023-01-27 | GSE186213 | GEO
Project description:This SuperSeries is composed of the SubSeries listed below.
2021-04-26 | GSE164381 | GEO
Project description:The identification of COVID-19 patients with high-risk of severe disease is a challenge in routine care. We performed blood RNA-seq gene expression analyses in severe hospitalized patients compared to healthy donors. Supervised and unsupervised analyses revealed a high abundance of CD177, a specific neutrophil activation marker, contributing to the clustering of severe patients. Gene abundance correlated with high serum levels of CD177 in severe patients. These results highlight neutrophil activation as a hallmark of severe disease and CD177 assessment as a reliable prognostic marker for routine care.
2021-05-27 | GSE171110 | GEO